Nephros is a commercial stage company that develops and sells water solutions to the medical and commercial markets. Co.'s filters, which are generally classified as ultrafilters, are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. Co.'s subsidiary, Specialty Renal Products, Inc., is developing a second generation of the OLpur H2H Hemodiafiltration (HDF) System, a medical device that enables nephrologists to provide HDF treatment to patients with end stage renal disease. The NEPH stock yearly return is shown above.
The yearly return on the NEPH stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NEPH annual return calculation with any dividends reinvested as applicable (on ex-dates).
|